Watson-Marlow — Pumpsil silicone tubing
USP Class VI Pumpsil silicone tubing, fully post-cured with very low leachables. Laser-etched with product code, description, lot number and use-by date for full traceability. Custom sizes to order.
Pumpsil platinum-cured tubing from Watson-Marlow
* Comprehensive stock of a wide range of sizes for next day delivery
* Absolute traceability with laser coded part number, lot number and use-by date
* High level of purity and clarity: very low leachables and extractables
* Ultra smooth bore to control protein binding and bacterial growth
* Fully documented biocompatibility, comprehensive validation pack
* Excellent flow stability for accurate process control
* Tight surface cure, non-tacky surface.
Absolute traceability
With the tubing part number, lot number and use-by date laser coded along the length of every tube, absolute traceability is now assured. The same data is printed on the tubing box label, bag label and certificate and so irrespective of whether the tubing is in store or in your process, identification of the tubing is simple and guaranteed.
Superior biocompatibility
A comprehensive validation pack is available for Pumpsil which details compliance with USP Class VI, ISO10993, FDA CFR177.2600 as well as other key details to help you validate your process.
Manufactured in an ISO1644-1 Class 7 (Class J/10,000) cleanroom dedicated to the manufacture of biopharmaceutical grade platinum-cured silicone, Pumpsil is entirely free of the 2,4 DCBA and other leachables associated with peroxide cured silicone.
Fully post-cured for 4 hours at 200C as part of the manufacturing process, Pumpsil exhibits exceptionally low extractables, helping to maintain the purity of your product.
Direct from the manufacturer in the UK.
www.wmtubing.com/Tubing/pumpsil.htm
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
